A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : KPC / Klebsiella pneumoniae carbapenemase

[Related PubMed/MEDLINE]
Total Number of Papers: 376
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   KPC  (>> Co-occurring Abbreviation)
Long Form:   Klebsiella pneumoniae carbapenemase
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Activity of ceftazidime-avibactam alone and in combination with polymyxin B against carbapenem-resistant Klebsiella pneumoniae in a tandem in vitro time-kill/in vivo Galleriamellonella survival model analysis. MIC
2020 Activity of Imipenem-Relebactam against Carbapenem-Resistant Escherichia coli Isolates from the United States in Relation to Clonal Background, Resistance Genes, Coresistance, and Region. CR, I-R, NDM, ST131
2020 Activity of temocillin against ESBL-, AmpC-, and/or KPC-producing Enterobacterales isolated in Poland. AmpC, ESBL, MICs
2020 An Update on Existing and Emerging Data for Meropenem-Vaborbactam. CRE, cUTIs
2020 Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization. CPE
2020 Carbapenem-Resistant KPC- and TEM-Producing Escherichia coli ST131 Isolated from a Hospitalized Patient with Urinary Tract Infection: First Isolation in Molise Region, Central Italy, July 2018. ---
2020 Characteristics and Evolution of Renal Transplant Recipients Infected by Carbapenemase-Producing Klebsiella pneumoniae. RT
2020 Detection in two hospitals of transferable ceftazidime-avibactam resistance in Klebsiella pneumoniae due to a novel VEB beta-lactamase variant with a Lys234Arg substitution, Greece, 2019. CAZ-AVI, ST, VEB
2020 Dynamic Epidemiology and Virulence Characteristics of Carbapenem-Resistant Klebsiella pneumoniae in Wenzhou, China from 2003 to 2016. CRKP, MLST, ST
10  2020 Early OXA-48-Producing Enterobacterales Isolates Recovered in a Spanish Hospital Reveal a Complex Introduction Dominated by Sequence Type 11 (ST11) and ST405 Klebsiella pneumoniae Clones. CPE, ST11
11  2020 Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China. CAZ/AVI, CRKP, MBL-KP
12  2020 Evaluation of Phenotypic and Genotypic Characteristics of Carbapnemases-producing Enterobacteriaceae and Its Prevalence in a Referral Hospital in Tehran City. NDM
13  2020 Genomic analysis of the first KPC-producing Klebsiella pneumoniae isolated from a patient in Riyadh: A new public health concern in Saudi Arabia. ST, WGS
14  2020 High-performance method to detection of Klebsiella pneumoniae Carbapenemase in Enterobacterales by LC-MS/MS. CREs
15  2020 In vitro activity of imipenem-relebactam against resistant phenotypes of Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples - SMART Surveillance Europe 2015-2017. IAIs, MBL, MDR, NPE, UTIs
16  2020 Klebsiella pneumoniae carbapenemase (KPC) producer resistant to ceftazidime-avibactam due to a deletion in the blaKPC3 gene. ---
17  2020 Meropenem-nacubactam activity against AmpC-overproducing and KPC-expressing Pseudomonas aeruginosa in a neutropenic murine lung infection model. CFU, ELF, MICs
18  2020 Novel IncR/IncP6 Hybrid Plasmid pCRE3-KPC Recovered from a Clinical KPC-2-Producing Citrobacter braakii Isolate. ---
19  2020 Outbreak of carbapenemase-producing Enterobacteriaceae associated with a contaminated water dispenser and sink drains in the cardiology units of a Korean hospital. CPE, ICUs, NDM, PFGE
20  2020 Outbreak of KPC-2-producing Klebsiella pneumoniae endowed with ceftazidime-avibactam resistance mediated through a VEB-1-mutant (VEB-25), Greece, September to October 2019. CZA, ST, VEB
21  2020 Rapid Identification of OXA-48-like, KPC, NDM, and VIM Carbapenemase-Producing Enterobacteriaceae From Culture: Evaluation of the RESIST-4 O.K.N.V. Multiplex Lateral Flow Assay. CPE, CRE, NDM, OXA, SBA, VIM
22  2020 Risk factors for Klebsiella pneumoniae carbapenemase (KPC) gene acquisition and clinical outcomes across multiple bacterial species. CPE, LTACH
23  2020 The Rate of Acquisition of Carbapenemase-Producing Enterobacteriaceae among Close Contact Patients Depending on Carbapenemase Enzymes. CPE, ICU, NDM-1
24  2020 Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae. BC, BSIs, CI, HR, ICU, KP
25  2020 Treatment of multidrug-resistant Gram-negative skin and soft tissue infections. CRE, GNB, MDR, SSTI
26  2019 A Multi-Centered Case-Case-Control Study of Factors Associated With Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae Infections in Children and Young Adults. CSE, LOS, ORs
27  2019 A novel disk-based detection method with superior sensitivity for beta-lactamase production in third-generation cephalosporin-resistant Enterobacteriaceae. AmpC, ESBL, MBL
28  2019 Activity of Imipenem-Relebactam and Comparator Agents against Genetically Characterized Isolates of Carbapenem-Resistant Enterobacteriaceae. CRE
29  2019 Activity of Meropenem with a Novel Broader-Spectrum beta-Lactamase Inhibitor, WCK 4234, against Gram-Negative Pathogens Endemic to New York City. ESBLs
30  2019 An Outbreak of KPC-Producing Klebsiella pneumoniae Linked with an Index Case of Community-Acquired KPC-Producing Isolate: Epidemiological Investigation and Whole Genome Sequencing Analysis. KPN, WGS
31  2019 Antimicrobial-Resistant Escherichia coli from Environmental Waters in Northern Colorado. AMR, ESBL
32  2019 Carbapenem-resistant Acinetobacter baumannii in patients with burn injury: A systematic review and meta-analysis. BVS, CRAB, MBL, SciELO
33  2019 Carbapenemase-Producing Enterobacterales in Algeria: A Systematic Review. CPE, NDM
34  2019 Carbapenemase-producing Enterobacteriaceae and Aeromonas spp. present in wastewater treatment plant effluent and nearby surface waters in the US. CPB, NDM, WWTP
35  2019 Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli. EA, EOT, ESBLs, FUP, MDR, MITT, TOC
36  2019 Changing epidemiology of KPC-producing Klebsiella pneumoniae in Argentina: Emergence of hypermucoviscous ST25 and high-risk clone ST307. PCR, PFGE, ST
37  2019 Clinical and epidemiological characteristics of KPC-producing Klebsiella pneumoniae from bloodstream infections in a tertiary referral center in Italy. BSI
38  2019 Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: Combination of tigecycline or doxycycline and gentamicin or amikacin. MICs
39  2019 Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy. CPE, SOT, VIM
40  2019 Community prevalence of carbapenemase-producing organisms in East London. CPOs, IMP, NDM, OXA-48, VIM
41  2019 Comparative Analysis of bla KPC Expression in Tn4401 Transposons and the Tn3-Tn4401 Chimera. IPM, MEM
42  2019 Comparison of Four Commercial Screening Assays for the Detection of blaKPC, blaNDM, blaIMP, blaVIM, and blaOXA48 in Rectal Secretion Collected by Swabs. CRE, OXA
43  2019 Diversity, Virulence, and Antimicrobial Resistance in Isolates From the Newly Emerging Klebsiella pneumoniae ST101 Lineage. AMR, MDR, STs
44  2019 Economic burden of inpatients infected with Klebsiella pneumoniae carbapenemase. ---
45  2019 Efficacy and Safety of Meropenem-Vaborbactam Versus Best Available Therapy for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Patients Without Prior Antimicrobial Failure: A Post Hoc Analysis. BAT, CI, CRE, EOT, MV, TOC
46  2019 Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae. CAZ-AVI, KPC-Kp
47  2019 Emergence of New Delhi Metallo-Beta-Lactamase (NDM) and Klebsiella pneumoniae Carbapenemase (KPC) Production by Escherichia coli and Klebsiella pneumoniae in Southern Vietnam and Appropriate Methods of Detection: A Cross-Sectional Study. CDT, CPE, MHT, NDM, PCR, SPC
48  2019 Endemicity of the High-Risk Clone Klebsiella pneumoniae ST340 Coproducing QnrB, CTX-M-15, and KPC-2 in a Brazilian Hospital. ESBL, STs
49  2019 Fecal Carriage and Epidemiology of Carbapenem-Resistant Enterobacteriaceae Among Hospitalized Patients in a University Hospital. CRE, ICU, MLST, PFGE, ST
50  2019 First clinical case of KPC-3-producing Klebsiella michiganensis in Europe. ---
51  2019 First evidence of KPC-producing ST258 Klebsiella pneumoniae in river water. ---
52  2019 First Report of Whole-Genome Sequence of Colistin-Resistant Klebsiella quasipneumoniae subsp. similipneumoniae Producing KPC-9 in India. ---
53  2019 Genomic Analysis Of A KPC-2-Producing Klebsiella Pneumoniae ST11 Outbreak From A Teaching Hospital In Shandong Province, China. ESBL, MLST, S1-PFGE, WGS
54  2019 Identification of blaVIM-1 Gene in ST307 and ST661 Klebsiella pneumoniae Clones in Italy: Old Acquaintances for New Combinations. ST258
55  2019 Identification, Characterization, and Formulation of a Novel Carbapenemase Intended to Prevent Antibiotic-Mediated Gut Dysbiosis. GI, NDM
56  2019 Imipenem/relebactam activity compared to other antimicrobials against non-MBL-producing carbapenem-resistant Enterobacteriaceae from an academic medical center. CRE, MICs
57  2019 Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae ST258 isolated from a Japanese patient without a history of foreign travel - a new public health concern in Japan: a case report. ---
58  2019 Klebsiella quasipneumoniae Provides a Window into Carbapenemase Gene Transfer, Plasmid Rearrangements, and Patient Interactions with the Hospital Environment. ---
59  2019 Meropenem-Vaborbactam as Salvage Therapy for Ceftazidime-Avibactam-Resistant Klebsiella pneumoniae Bacteremia and Abscess in a Liver Transplant Recipient. ---
60  2019 Molecular and phenotypical characterization of two cases of antibiotic-driven ceftazidime-avibactam resistance in bla KPC-3-harboring Klebsiella pneumoniae. CAZ-AVI, CRE
61  2019 Molecular Epidemiology of Plasmid-Mediated Fosfomycin Resistance Gene Determinants in Klebsiella pneumoniae Carbapenemase-Producing Klebsiella pneumoniae Isolates in China. CRKP, PFGE
62  2019 Nitro-Carba test, a novel and simple chromogenic phenotypic method for rapid screening of carbapenemase-producing Enterobacteriaceae. CPE, ETP, IPM, MBL, MEM, MICs, NCT
63  2019 Patient-to-Patient Transmission of Klebsiella pneumoniae Carbapenemase Variants with Reduced Ceftazidime-Avibactam Susceptibility. ---
64  2019 Pharmacokinetics/Pharmacodynamics of Vaborbactam, a Novel Beta-Lactamase Inhibitor, in Combination with Meropenem. AUCs, PD, PK
65  2019 Polymyxins: To Combine or Not to Combine? CRAB, CRE, CRPA, XDR
66  2019 Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections. CRE
67  2019 Rapid Identification of Carbapenemase-producing Klebsiella pneumoniae strains by Matrix-Assisted Laser Desorption/Ionization-Time of Flight using Vitek Mass Spectrometry System. AST, MALDI, MALDI-TOF, MS, RUO
68  2019 Reconstruction of the Genomes of Drug-Resistant Pathogens for Outbreak Investigation through Metagenomic Sequencing. ---
69  2019 Rectal screening for carbapenemase-producing Enterobacteriaceae: a proposed workflow. CPE
70  2019 The threat of carbapenem-resistant bacteria in the environment: Evidence of widespread contamination of reservoirs at a global scale. AR, CRE, NDM, OXA-48, VIM
71  2019 Tracing local and regional clusters of carbapenemase-producing Klebsiella pneumoniae ST512 with whole genome sequencing, Finland, 2013 to 2018. cgMLST, HCF, WGS
72  2019 Use of a cohorting-unit and systematic surveillance cultures to control a Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae outbreak. ---
73  2018 A 4.5-Year Within-Patient Evolution of a Colistin-Resistant Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Sequence Type 258. ---
74  2018 A Large, Refractory Nosocomial Outbreak of Klebsiella pneumoniae Carbapenemase-Producing Escherichia coli Demonstrates Carbapenemase Gene Outbreaks Involving Sink Sites Require Novel Approaches to Infection Control. CMFT, CRE, ST216
75  2018 Acquisition of Carbapenemase-Producing Enterobacteriaceae in Solid Organ Transplantation Recipients. CPE, OR, PCR, SOT
76  2018 Activity of Meropenem-Vaborbactam against Carbapenem-Resistant Enterobacteriaceae in a Murine Model of Pyelonephritis. ---
77  2018 Activity of Meropenem-Vaborbactam in Mouse Models of Infection Due to KPC-Producing Carbapenem-Resistant Enterobacteriaceae. ---
78  2018 Activity of Simulated Human Dosage Regimens of Meropenem and Vaborbactam against Carbapenem-Resistant Enterobacteriaceae in an In Vitro Hollow-Fiber Model. ---
79  2018 Carriage trends and fitness cost of MDROs in Lebanese nursing homes. ESBL, MBL, MDROs
80  2018 Characterization of the AmpC beta-Lactamase from Burkholderia multivorans. ---
81  2018 Clinical factors predicting persistent carriage of Klebsiella pneumoniae carbapenemase-producing carbapenem-resistant Enterobacteriaceae among patients with known carriage. AOR, CI, CRE
82  2018 Comparative Evaluation of Four Phenotypic Methods for Detection of Class A and B Carbapenemase-Producing Enterobacteriaceae in China. CPE, CRE, mCIM, MHA, MHT
83  2018 Detection of 16S rRNA and KPC Genes from Complex Matrix Utilizing a Molecular Inversion Probe Assay for Next-Generation Sequencing. AR, MIP, NGS
84  2018 Detection of high-risk carbapenem-resistant Klebsiella pneumoniae and Enterobacter cloacae isolates using volatile molecular profiles. AUROC, CRE, ST258
85  2018 Determination of MIC and disk diffusion quality control guidelines for meropenem-vaborbactam, a novel carbapenem/boronic acid beta-lactamase inhibitor combination. ---
86  2018 Diversity among blaKPC-containing plasmids in Escherichia coli and other bacterial species isolated from the same patients. ---
87  2018 Draft genome sequence of KPC-2-producing Pseudomonas aeruginosa recovered from a bloodstream infection sample in Brazil. CRISPRs, STs
88  2018 Emergence of Resistance to Colistin During the Treatment of Bloodstream Infection Caused by Klebsiella pneumoniae Carbapenemase-Producing Klebsiella pneumoniae. ---
89  2018 Evaluation of Modified Hodge Test as a Non-molecular Assay for Accurate Detection of KPC-producing Klebsiella pneumoniae. CLSI, MHT
90  2018 Evaluation of the FilmArray Blood Culture Identification Panel on Detection of Pathogenic Microorganisms in Positive Blood Cultures: the First Clinical Report in Japan. BCID, FA, MALDI-TOF MS
91  2018 Further Spread of a blaKPC-Harboring Untypeable Plasmid in Enterobacteriaceae in China. CRE, SNPs
92  2018 Game Changers: New beta-Lactamase Inhibitor Combinations Targeting Antibiotic Resistance in Gram-Negative Bacteria. ---
93  2018 Genetic Diversity of KPC-Producing Escherichia coli, Klebsiella oxytoca, Serratia marcescens, and Citrobacter freundii Isolates from Argentina. ETB
94  2018 Identification of extended spectrum beta lactamases, AmpC and carbapenemase production among isolates of Escherichia coli in North Indian tertiary care centre. ESBL, MBL
95  2018 In vitro activity of minocycline combined with aminoglycosides against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. MPC, MSW
96  2018 Klebsiella pneumoniae Carbapenemase Producers in South Korea between 2013 and 2015. ---
97  2018 Management of KPC-producing Klebsiella pneumoniae infections. ---
98  2018 Meropenem and Vaborbactam: Stepping up the Battle against Carbapenem-resistant Enterobacteriaceae. CRE, MV, VAB
99  2018 Meropenem-vaborbactam for adults with complicated urinary tract and other invasive infections. CRE
100  2018 Meropenem-vaborbactam for the treatment of complicated urinary tract infections including acute pyelonephritis. ---